Clinical Translation

Overview

Clinical translation is the process of converting basic scientific and preclinical discoveries into safe, effective, and validated interventions for use in patients, bridging the gap between laboratory findings and clinical practice. It encompasses the staged development of diagnostics, therapeutics, and devices, from mechanistic insight through preclinical models and early-phase human studies to broader clinical adoption, and it depends on rigorous evidence, regulatory and ethical oversight, and reproducible methodology. Enabling tools are central: molecular biomarkers support diagnosis, patient stratification, and monitoring of treatment response, while proteomic and genomic techniques extend applications across cancer, diagnostics, and personalized medicine. Emerging modalities illustrate both the promise and the challenges of translation; gene therapy for conditions such as heart failure and the clinical development of stem-cell-based approaches show how innovative treatments progress toward the clinic, while the accompanying ethical and interdisciplinary considerations, particularly in stem-cell research, shape responsible implementation. Translation is inherently multidisciplinary, integrating molecular biology, clinical medicine, study design, and ethics to ensure that interventions are not only mechanistically sound but also demonstrably beneficial and safe in real-world care. Research themes include biomarker discovery and qualification, the design of preclinical and early clinical studies, the evaluation of advanced therapies, and the ethical frameworks that govern their use. The overarching aim is to deliver validated advances that improve patient outcomes and the quality of care.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

This page summarises published research for orientation; it is not medical or professional advice.

Related topics